115 related articles for article (PubMed ID: 26087354)
1. Double-Duct Sign in the Clinical Context.
Sinha R; Gardner T; Padala K; Greenaway JR; Joy D
Pancreas; 2015 Aug; 44(6):967-70. PubMed ID: 26087354
[TBL] [Abstract][Full Text] [Related]
2. Double-duct sign: do not forget the gallstones.
Oterdoom LH; van Weyenberg SJ; de Boer NK
J Gastrointestin Liver Dis; 2013 Dec; 22(4):447-50. PubMed ID: 24369328
[TBL] [Abstract][Full Text] [Related]
3. Endosonography for Pancreatic Duct Dilatation without Definite Pathology on Ultrasonography.
Chen CH; Yang CC; Yeh YH
Hepatogastroenterology; 2014 May; 61(131):842-8. PubMed ID: 26176084
[TBL] [Abstract][Full Text] [Related]
4. Dilation of both pancreatic duct and the common bile duct on computed tomography and magnetic resonance imaging scans in patients with or without obstructive jaundice.
Krishna N; Tummala P; Reddy AV; Mehra M; Agarwal B
Pancreas; 2012 Jul; 41(5):767-72. PubMed ID: 22450366
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance cholangiopancreatography of pancreaticobiliary duct dilation due to pancreatic carcinoma and chronic pancreatitis.
Meng Z; Xu YK; Zhang YP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):113-5. PubMed ID: 18524063
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance cholangiopancreatography study of pancreaticobiliary maljunction and pancreaticobiliary diseases.
Wang CL; Ding HY; Dai Y; Xie TT; Li YB; Cheng L; Wang B; Tang RH; Nie WX
World J Gastroenterol; 2014 Jun; 20(22):7005-10. PubMed ID: 24944495
[TBL] [Abstract][Full Text] [Related]
7. Endosonography for suspected obstructive jaundice with no definite pathology on ultrasonography.
Chen CH; Yang CC; Yeh YH; Yang T; Chung TC
J Formos Med Assoc; 2015 Sep; 114(9):820-8. PubMed ID: 24090635
[TBL] [Abstract][Full Text] [Related]
8. Double-duct sign in the era of endoscopic ultrasound: the prevalence of occult pancreaticobiliary malignancy.
Cohen J; Sawhney MS; Pleskow DK; Chuttani R; Patel NJ; Sheridan J; Berzin TM
Dig Dis Sci; 2014 Sep; 59(9):2280-5. PubMed ID: 24705640
[TBL] [Abstract][Full Text] [Related]
9. The double duct sign in patients with malignant and benign pancreatic lesions.
Menges M; Lerch MM; Zeitz M
Gastrointest Endosc; 2000 Jul; 52(1):74-7. PubMed ID: 10882966
[TBL] [Abstract][Full Text] [Related]
10. The double duct sign.
Ahualli J
Radiology; 2007 Jul; 244(1):314-5. PubMed ID: 17581912
[No Abstract] [Full Text] [Related]
11. Diagnostic value of MRCP and indications for ERCP.
Sakai Y; Tsuyuguchi T; Tsuchiya S; Sugiyama H; Miyakawa K; Ebara M; Saisho H; Yokosuka O
Hepatogastroenterology; 2007 Dec; 54(80):2212-5. PubMed ID: 18265635
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of 3-dimensional balanced turbo-field-echo magnetic resonance cholangiopancreatography at 3 T: prospective intraindividual comparison with 3-dimensional turbo-spin-echo magnetic resonance cholangiopancreatography.
Itatani R; Namimoto T; Takaoka H; Katahira K; Noda S; Toyonari N; Yamashita Y
J Comput Assist Tomogr; 2015; 39(1):19-24. PubMed ID: 25299796
[TBL] [Abstract][Full Text] [Related]
13. Can red cell distribution width help to discriminate benign from malignant biliary obstruction? A retrospective single center analysis.
Beyazit Y; Kekilli M; Ibis M; Kurt M; Sayilir A; Onal IK; Purnak T; Oztas E; Tas A; Yesil Y; Arhan M
Hepatogastroenterology; 2012; 59(117):1469-73. PubMed ID: 22683963
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of a new sequence of magnetic resonance cholangio-pancreatography in thick cut and one shot acquisition].
Mougenel JL; Hudziak H; Ernst O; Dupas B; Lefevre F; Barraud H; Watelet J; Cezard O; Regent D; Bigard MA
Gastroenterol Clin Biol; 2000 Oct; 24(10):888-95. PubMed ID: 11084424
[TBL] [Abstract][Full Text] [Related]
15. Are a Double Duct Sign or Endoscopic Biopsies Reliable Predictors of Malignancy in Periampullary Lesions.
Ten Berge JC; Suker M; Bruno MJ; Poley JW; Dwarkasing R; Biermann K; van Eijck CH
Dig Surg; 2015; 32(4):306-11. PubMed ID: 26138752
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic duct strictures: identifying risk of malignancy.
Kalady MF; Peterson B; Baillie J; Onaitis MW; Abdul-Wahab OI; Howden JK; Jowell PS; Branch MS; Clary BM; Pappas TN; Tyler DS
Ann Surg Oncol; 2004 Jun; 11(6):581-8. PubMed ID: 15150064
[TBL] [Abstract][Full Text] [Related]
17. Value of serum bilirubin levels in selecting patients for magnetic resonance cholangiopancreatography.
Haroun AA; Al-Hadidi AM; Tarawneh IS; Mahafza WS; Shennak M
Hepatogastroenterology; 2007 Jun; 54(76):995-8. PubMed ID: 17629024
[TBL] [Abstract][Full Text] [Related]
18. Role of magnetic resonance cholangiopancreatography for choledocholithiasis: analysis of patients with negative MRCP.
Chang JH; Lee IS; Lim YS; Jung SH; Paik CN; Kim HK; Kim TH; Kim CW; Han SW; Choi MG; Jung IS
Scand J Gastroenterol; 2012 Feb; 47(2):217-24. PubMed ID: 22149906
[TBL] [Abstract][Full Text] [Related]
19. Periductal hypoechoic sign: an endosonographic finding associated with pancreatic malignancy.
Lee SH; Ozden N; Pawa R; Hwangbo Y; Pleskow DK; Chuttani R; Sawhney MS
Gastrointest Endosc; 2010 Feb; 71(2):249-55. PubMed ID: 19922915
[TBL] [Abstract][Full Text] [Related]
20. MR cholangiopancreatography of bile and pancreatic duct abnormalities with emphasis on the single-shot fast spin-echo technique.
Vitellas KM; Keogan MT; Spritzer CE; Nelson RC
Radiographics; 2000; 20(4):939-57; quiz 1107-8, 1112. PubMed ID: 10903685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
